Role of autophagy in cancer prevention, development and therapy

Essays in Biochemistry

Volumn 55, Issue 1, 2013, Pages 133-151

  Helgason, G Vignir ^a   Holyoake, Tessa L ^a   Ryan, Kevin M ^b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b BEATSON INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

Author keywords

Anticancer therapy; Autophagosome; Chloroquine; Chronic myeloid leukaemia; Haemopoieticstem cell; Hydroxychloroquine; Tumorigenesis

Indexed keywords

ANTINEOPLASTIC AGENT; ENZYME INHIBITOR;

ANIMAL; ARTICLE; AUTOPHAGY; DRUG DEVELOPMENT; DRUG EFFECT; HUMAN; METABOLISM; NEOPLASM;

ANIMALS; ANTINEOPLASTIC AGENTS; AUTOPHAGY; DRUG DISCOVERY; ENZYME INHIBITORS; HUMANS; NEOPLASMS;

EID: 84892166326     PISSN: 00711365     EISSN: None     Source Type: Journal    
DOI: 10.1042/BSE0550133     Document Type: Article

References (65)

1. Klionsky, D.J. (2007) Autophagy: from phenomenology to molecular understanding in less than a decade. Nat. Rev. Mol. Cell Biol. 8, 931-937
2. Yang, Z. and Klionsky, D.J. (2010) Mammalian autophagy: core molecular machinery and signaling regulation. Curr. Opin. Cell Biol. 22, 124-131
3. Xie, Z. and Klionsky, D.J. (2007) Autophagosome formation: core machinery and adaptations. Nat. Cell Biol. 9, 1102-1109
4. Mizushima, N. (2007) Autophagy: process and function. Genes Dev. 21, 2861-2873
5. Mizushima, N. (2010) The role of the Atg1/ULK1 complex in autophagy regulation. Curr. Opin. Cell Biol. 22, 132-139
6. Hosokawa, N., Hara, T., Kaizuka, T., Kishi, C., Takamura, A., Miura, Y., Iemura, S., Natsume, T., Takehana, K., Yamada, N. et al. (2009) Nutrient-dependent mTORC1 association with the ULK1-Atg13-FIP200 complex required for autophagy. Mol. Biol. Cell 20, 1981-1991
7. Jung, C.H., Jun, C.B., Ro, S.H., Kim, Y.M., Otto, N.M., Cao, J., Kundu, M., and Kim, D.H. (2009) ULK-Atg13-FIP200 complexes mediate mTOR signaling to the autophagy machinery. Mol. Biol. Cell 20, 1992-2003
8. Simonsen, A. and Tooze, S.A. (2009) Coordination of membrane events during autophagy by multiple class III PI3-kinase complexes. J. Cell Biol. 186, 773-782
9. Maiuri, M.C., Le Toumelin, G., Criollo, A., Rain, J.C., Gautier, F., Juin, P., Tasdemir, E., Pierron, G., Troulinaki, K., Tavernarakis, N. et al. (2007) Functional and physical interaction between Bcl-X(L) and a BH3-like domain in Beclin-1. EMBO J. 26, 2527-2539
10. Levine, B., Sinha, S. and Kroemer, G. (2008) Bcl-2 family members: dual regulators of apoptosis and autophagy. Autophagy 4, 600-606
11. Ohsumi, Y. (2001) Molecular dissection of autophagy: two ubiquitin-like systems. Nat. Rev. Mol. Cell Biol. 2, 211-216
12. Geng, J. and Klionsky, D.J. (2008) The Atg8 and Atg12 ubiquitin-like conjugation systems in macroautophagy. 'Protein modifications: beyond the usual suspects' review series. EMBO Rep. 9, 859-864
13. Klionsky, D.J., Abdalla, F.C., Abeliovich, H., Abraham, R.T., Acevedo-Arozena, A., Adeli, K., Agholme, L., Agnello, M., Agostinis, P., Aguirre-Ghiso, J.A. et al. (2012) Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy 8, 445-544
14. Eskelinen, E.L., Tanaka, Y. and Saftig, P. (2003) At the acidic edge: emerging functions for lysosomal membrane proteins. Trends Cell Biol. 13, 137-145
15. Gutierrez, M.G., Munafo, D.B., Beron, W. and Colombo, M.I. (2004) Rab7 is required for the normal progression of the autophagic pathway in mammalian cells. J. Cell Sci. 117, 2687-2697
16. Jager, S., Bucci, C., Tanida, I., Ueno, T., Kominami, E., Saftig, P. and Eskelinen, E.L. (2004) Role for Rab7 in maturation of late autophagic vacuoles. J. Cell Sci. 117, 4837-4848
17. Liang, C., Lee, J.S., Inn, K.S., Gack, M.U., Li, Q., Roberts, E.A., Vergne, I., Deretic, V., Feng, P., Akazawa, C. and Jung, J.U. (2008) Beclin1-binding UVRAG targets the class C Vps complex to coordinate autophagosome maturation and endocytic trafficking. Nat. Cell Biol. 10, 776-787
18. Laplante, M. and Sabatini, D.M. (2012) mTOR signaling in growth control and disease. Cell 149, 274-293
19. Jung, C.H., Ro, S.H., Cao, J., Otto, N.M. and Kim, D.H. (2010) mTOR regulation of autophagy. FEBS Lett. 584, 1287-1295
20. Ma, L., Chen, Z., Erdjument-Bromage, H., Tempst, P. and Pandolfi, P.P. (2005) Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis. Cell 121, 179-193
21. Furuta, S., Hidaka, E., Ogata, A., Yokota, S. and Kamata, T. (2004) Ras is involved in the negative control of autophagy through the class I PI3-kinase. Oncogene 23, 3898-3904
22. Pattingre, S., Bauvy, C. and Codogno, P. (2003) Amino acids interfere with the ERK1/2-dependent control of macroautophagy by controlling the activation of Raf-1 in human colon cancer HT-29 cells. J. Biol. Chem. 278, 16667-16674
23. Guo, J.Y., Chen, H.Y., Mathew, R., Fan, J., Strohecker, A.M., Karsli-Uzunbas, G., Kamphorst, J.J., Chen, G., Lemons, J.M., Karantza, V. et al. (2011) Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis. Genes Dev. 25, 460-470
24. Gwinn, D.M., Shackelford, D.B., Egan, D.F., Mihaylova, M.M., Mery, A., Vasquez, D.S., Turk, B.E. and Shaw, R.J. (2008) AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol. Cell 30, 214-226
25. Muller, P.A. and Vousden, K.H. (2013) p53 mutations in cancer. Nat. Cell Biol. 15, 2-8
26. Crighton, D., Wilkinson, S., O'Prey, J., Syed, N., Smith, P., Harrison, P.R., Gasco, M., Garrone, O., Crook, T. and Ryan, K.M. (2006) DRAM, a p53-induced modulator of autophagy, is critical for apoptosis. Cell 126, 121-134
27. Feng, Z., Zhang, H., Levine, A.J. and Jin, S. (2005) The coordinate regulation of the p53 and mTOR pathways in cells. Proc. Natl. Acad. Sci. U.S.A. 102, 8204-8209
28. Tasdemir, E., Maiuri, M.C., Galluzzi, L., Vitale, I., Djavaheri-Mergny, M., D'Amelio, M., Criollo, A., Morselli, E., Zhu, C., Harper, F. et al. (2008) Regulation of autophagy by cytoplasmic p53. Nat. Cell Biol. 10, 676-687
29. Martinou, J.C. and Youle, R.J. (2011) Mitochondria in apoptosis: Bcl-2 family members and mitochondrial dynamics. Dev. Cell 21, 92-101
30. Pattingre, S., Tassa, A., Qu, X., Garuti, R., Liang, X.H., Mizushima, N., Packer, M., Schneider, M.D. and Levine, B. (2005) Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell 122, 927-939
31. Liang, X.H., Jackson, S., Seaman, M., Brown, K., Kempkes, B., Hibshoosh, H. and Levine, B. (1999) Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature 402, 672-676
32. Yue, Z., Jin, S., Yang, C., Levine, A.J. and Heintz, N. (2003) Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor. Proc. Natl. Acad. Sci. U.S.A. 100, 15077-15082
33. Qu, X., Yu, J., Bhagat, G., Furuya, N., Hibshoosh, H., Troxel, A., Rosen, J., Eskelinen, E.L., Mizushima, N., Ohsumi, Y. et al. (2003) Promotion of tumori genesis by heterozygous disruption of the beclin 1 autophagy gene. J. Clin. Invest. 112, 1809-1820
34. Kang, M.R., Kim, M.S., Oh, J.E., Kim, Y.R., Song, S.Y., Kim, S.S., Ahn, C.H., Yoo, N.J. and Lee, S.H. (2009) Frameshift mutations of autophagy-related genes ATG2B, ATG5, ATG9B and ATG12 in gastric and colorectal cancers with microsatellite instability. J. Pathol. 217, 702-706
35. Mortensen, M., Soilleux, E.J., Djordjevic, G., Tripp, R., Lutteropp, M., Sadighi-Akha, E., Stranks, A.J., Glanville, J., Knight, S., Jacobsen, S.E. et al. (2011) The autophagy protein Atg7 is essential for hematopoietic stem cell maintenance. J. Exp. Med. 208, 455-467
36. Takamura, A., Komatsu, M., Hara, T., Sakamoto, A., Kishi, C., Waguri, S., Eishi, Y., Hino, O., Tanaka, K. and Mizushima, N. (2011) Autophagy-deficient mice develop multiple liver tumors. Genes Dev. 25, 795-800
37. Warr, M.R., Binnewies, M., Flach, J., Reynaud, D., Garg, T., Malhotra, R., Debnath, J. and Passegue, E. (2013) FOXO3A directs a protective autophagy program in haematopoietic stem cells. Nature 494, 323-327
38. Liu, F., Lee, J.Y., Wei, H., Tanabe, O., Engel, J.D., Morrison, S.J. and Guan, J.L. (2010) FIP200 is required for the cell-autonomous maintenance of fetal hematopoietic stem cells. Blood 116, 4806-4814
39. Mathew, R., Karp, C.M., Beaudoin, B., Vuong, N., Chen, G., Chen, H.Y., Bray, K., Reddy, A., Bhanot, G., Gelinas, C. et al. (2009) Autophagy suppresses tumorigenesis through elimination of p62. Cell 137, 1062-1075
40. Mathew, R., Kongara, S., Beaudoin, B., Karp, C.M., Bray, K., Degenhardt, K., Chen, G., Jin, S. and White, E. (2007) Autophagy suppresses tumor progression by limiting chromosomal instability. Genes Dev. 21, 1367-1381
41. Kuroda, J., Puthalakath, H., Cragg, M.S., Kelly, P.N., Bouillet, P., Huang, D.C., Kimura, S., Ottmann, O.G., Druker, B.J., Villunger, A. et al. (2006) Bim and Bad mediate imatinib-induced killing of Bcr/Abl+ leukemic cells, and resistance due to their loss is overcome by a BH3 mimetic. Proc. Natl. Acad. Sci. U.S.A. 103, 14907-14912
42. Bellodi, C., Lidonnici, M.R., Hamilton, A., Helgason, G.V., Soliera, A.R., Ronchetti, M., Galavotti, S., Young, K.W., Selmi, T., Yacobi, R. et al. (2009) Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells. J. Clin. Invest. 119, 1109-1123
43. Paglin, S., Hollister, T., Delohery, T., Hackett, N., McMahill, M., Sphicas, E., Domingo, D. and Yahalom, J. (2001) A novel response of cancer cells to radiation involves autophagy and formation of acidic vesicles. Cancer Res. 61, 439-444
44. Amaravadi, R.K., Yu, D., Lum, J.J., Bui, T., Christophorou, M.A., Evan, G.I., Thomas-Tikhonenko, A. and Thompson, C.B. (2007) Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma. J. Clin. Invest. 117, 326-336
45. Zinn, R.L., Gardner, E.E., Dobromilskaya, I., Murphy, S., Marchionni, L., Hann, C.L. and Rudin, C.M. (2013) Combination treatment with ABT-737 and chloroquine in preclinical models of small cell lung cancer. Mol. Cancer 12, 16
46. Saleem, A., Dvorzhinski, D., Santanam, U., Mathew, R., Bray, K., Stein, M., White, E. and DiPaola, R.S. (2012) Effect of dual inhibition of apoptosis and autophagy in prostate cancer. Prostate 72, 1374-1381
47. White, E. and DiPaola, R.S. (2009) The double-edged sword of autophagy modulation in cancer. Clin. Cancer Res. 15, 5308-5316
48. Tannenbaum, A. and Silverstone, H. (1949) The influence of the degree of caloric restriction on the formation of skin tumors and hepatomas in mice. Cancer Res. 9, 724-727
49. Thompson, H.J., Zhu, Z. and Jiang, W. (2003) Dietary energy restriction in breast cancer prevention. J. Mammary Gland Biol. Neoplasia 8, 133-142
50. Klurfeld, D.M., Welch, C.B., Davis, M.J. and Kritchevsky, D. (1989) Determination of degree of energy restriction necessary to reduce DMBA-induced mammary tumorigenesis in rats during the promotion phase. J. Nutr. 119, 286-291
51. Colman, R.J., Anderson, R.M., Johnson, S.C., Kastman, E.K., Kosmatka, K.J., Beasley, T.M., Allison, D.B., Cruzen, C., Simmons, H.A., Kemnitz, J.W. and Weindruch, R. (2009) Caloric restriction delays disease onset and mortality in rhesus monkeys. Science 325, 201-204
52. Rubinsztein, D.C., Marino, G. and Kroemer, G. (2011) Autophagy and aging. Cell 146, 682-695
53. Dunn, S.E., Kari, F.W., French, J., Leininger, J.R., Travlos, G., Wilson, R. and Barrett, J.C. (1997) Dietary restriction reduces insulin-like growth factor I levels, which modulates apoptosis, cell proliferation, and tumor progression in p53-deficient mice. Cancer Res. 57, 4667-4672
54. De Lorenzo, M.S., Baljinnyam, E., Vatner, D.E., Abarzua, P., Vatner, S.F. and Rabson, A.B. (2011) Caloric restriction reduces growth of mammary tumors and metastases. Carcinogenesis 32, 1381-1387
55. Lashinger, L.M., Malone, L.M., Brown, G.W., Daniels, E.A., Goldberg, J.A., Otto, G., Fischer, S.M. and Hursting, S.D. (2011) Rapamycin partially mimics the anticancer effects of calorie restriction in a murine model of pancreatic cancer. Cancer Prev. Res. 4, 1041-1051
56. Safdie, F., Brandhorst, S., Wei, M., Wang, W., Lee, C., Hwang, S., Conti, P.S., Chen, T.C. and Longo, V.D. (2012) Fasting enhances the response of glioma to chemo- and radiotherapy. PLoS ONE 7, e44603
57. Raffaghello, L., Lee, C., Safdie, F.M., Wei, M., Madia, F., Bianchi, G. and Longo, V.D. (2008) Starvation-dependent differential stress resistance protects normal but not cancer cells against high-dose chemotherapy. Proc. Natl. Acad. Sci. U.S.A. 105, 8215-8220
58. Helgason, G.V., Karvela, M. and Holyoake, T.L. (2011) Kill one bird with two stones: potential efficacy of BCR-ABL and autophagy inhibition in CML. Blood 118, 2035-2043
59. Galavotti, S., Bartesaghi, S., Faccenda, D., Shaked-Rabi, M., Sanzone, S., McEvoy, A., Dinsdale, D., Condorelli, F., Brandner, S., Campanella, M. et al. (2013) The autophagyassociated factors DRAM1 and p62 regulate cell migration and invasion in glioblastoma stem cells. Oncogene 32, 699-712
60. Michaud, M., Martins, I., Sukkurwala, A.Q., Adjemian, S., Ma, Y., Pellegatti, P., Shen, S., Kepp, O., Scoazec, M., Mignot, G. et al. (2011) Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice. Science 334, 1573-1577
61. Maycotte, P., Aryal, S., Cummings, C.T., Thorburn, J., Morgan, M.J. and Thorburn, A. (2012) Chloroquine sensitizes breast cancer cells to chemotherapy independent of autophagy. Autophagy 8, 200-212
62. McAfee, Q., Zhang, Z., Samanta, A., Levi, S.M., Ma, X.H., Piao, S., Lynch, J.P., Uehara, T., Sepulveda, A.R., Davis, L.E. et al. (2012) Autophagy inhibitor Lys05 has single-agent antitumor activity and reproduces the phenotype of a genetic autophagy deficiency. Proc. Natl. Acad. Sci. U.S.A. 109, 8253-8258
63. Liu, J., Xia, H., Kim, M., Xu, L., Li, Y., Zhang, L., Cai, Y., Norberg, H.V., Zhang, T., Furuya, T. et al. (2011) Beclin1 controls the levels of p53 by regulating the deubiquitination activity of USP10 and USP13. Cell 147, 223-234
64. Schafranek, L., Leclercq, T.M., White, D.L. and Hughes, T.P. (2013) Clarithromycin enhances dasatinib-induced cell death in chronic myeloid leukemia cells, by inhibition of late stage autophagy. Leuk. Lymphoma 54, 198-201
65. Carella, A.M., Beltrami, G., Pica, G., Carella, A. and Catania, G. (2012) Clarithromycin potentiates tyrosine kinase inhibitor treatment in patients with resistant chronic myeloid leukemia. Leuk. Lymphoma 53, 1409-1411